Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,2 USD | +1,59% | +1,59% | -56,16% |
Attività
Numero di dipendenti: 179
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Precision Oncology Drugs
100,0
%
| 132 | 100,0 % | 51 | 100,0 % | -61,21% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
51,1
%
| 15 | 11,5 % | 26 | 51,1 % | +71,71% |
Switzerland
28,4
%
| 117 | 88,5 % | 15 | 28,4 % | -87,56% |
Japan
20,5
%
| - | - | 11 | 20,5 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Lloyd Segal
CEO | Chief Executive Officer | 60 | 01/06/16 |
Steve Forte
DFI | Director of Finance/CFO | 45 | 01/10/19 |
Michael Zinda
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/05/19 |
Maria Koehler
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/05/19 |
Robin T. Garner
IRC | Investor Relations Contact | - | - |
Daniel Bélanger
HRO | Human Resources Officer | - | 09/05/23 |
Philip Herman
PRN | Corporate Officer/Principal | - | 05/01/22 |
Kim Seth
PRN | Corporate Officer/Principal | - | 01/06/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 01/03/19 |
Lloyd Segal
CEO | Chief Executive Officer | 60 | 01/06/16 |
Ann Rhoads
BRD | Director/Board Member | 58 | 10/06/20 |
Todd Foley
BRD | Director/Board Member | 52 | 01/06/17 |
David Bonita
BRD | Director/Board Member | 48 | 01/09/19 |
Susan Molineaux
BRD | Director/Board Member | 70 | 08/06/23 |
Briggs Morrison
BRD | Director/Board Member | 65 | 01/06/17 |
Thomas Civik
CHM | Chairman | 55 | 07/09/21 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 01/11/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 42 182 177 | 41 737 875 ( 98,95 %) | 0 | 98,95 % |
Coordinate società
Repare Therapeutics, Inc.
7171 Frederick-Banting Suite 270
H4S 1Z9, Saint-Laurent
+
http://www.reparerx.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-56,16% | 135 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione RPTX
- Società Repare Therapeutics Inc.